| Beyond Limitations, Inc. | |
|
6448 S. Mcclintock Drive, Tempe, AZ 85283 | |
| (602) 750-6778 | |
| (480) 820-5958 |
| Full Name | Beyond Limitations, Inc. |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 6448 S. Mcclintock Drive, Tempe, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982726816 | NPI | - | NPPES |
| 614755800 | Other | DC | US DOL FECA |
| 614755800 | Other | KY | US DOL FECA |
| AZ0463410 | Other | AZ | BLUECROSS BLUESHIELD AZ |
| 614755800 | Other | CA | US DOL FECA |
| Mailing Address | Practice Location Address |
|---|---|
| Beyond Limitations, Inc. P.o. Box 11076, Tempe, AZ 85284-0018 Ph: (602) 750-6778 | Beyond Limitations, Inc. 6448 S. Mcclintock Drive, Tempe, AZ 85283 Ph: (602) 750-6778 |
News Archive
GE Healthcare today announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic agent approved by the FDA will be available. Late in the second quarter of 2014, Vizamyl will be available to imaging centers near East Rutherford, NJ, Woburn, MA, Beltsville, MD, East Lansing, MI, Dallas, TX, Phoenix, AZ and Colton, CA.
The mechanisms underpinning concussion, traumatic brain injury, and chronic traumatic encephalopathy, and the relationships between these disorders, are poorly understood.
Food Technology Service, Inc. had revenues of $761,230 during the second quarter of 2010 compared to revenues of $652,724 for the same period in 2009. This is an increase of approximately 16.4 percent. The Company had net income before taxes during the second quarter of 2010 of $277,624 compared to net income of $165,926 during the second quarter of 2009. This is an increase of approximately 67.3 percent.
In the search for new approaches to treat ERBB2 (also known as HER2) positive breast cancers that have become drug-resistant, Dartmouth's Norris Cotton Cancer Center investigator Manabu Kurokawa, PhD, led a team in discovery of a novel cancer resistance mechanism with findings published in Cell Cycle.
Corthera Inc. has announced that results from Pre-RELAX-AHF, the Phase II portion of a Phase II/III multicenter, randomized, double-blind, placebo-controlled international study, demonstrated promising efficacy and safety for relaxin, the company's investigational drug for treatment of acute heart failure (AHF).
› Verified 5 days ago
Ms. Susan L Fetter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 215 W Lodge Dr, Tempe, AZ 85283 Phone: 480-730-4103 Fax: 480-897-0014 | |
Angela Holly, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 E Southern Ave, 310, Tempe, AZ 85282 Phone: 602-567-9881 | |
Ms. Kelly Dunn Will, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 548 E Laguna Dr, Tempe, AZ 85282 Phone: 480-620-4226 | |
Mrs. Rachel Ann Jackson Belanger, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3311 S Holbrook Ln, Tempe, AZ 85282 Phone: 480-518-4602 | |
Cheryl Ray, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3205 S Rural Rd, Tempe, AZ 85282 Phone: 480-730-7100 | |
Lilian Quizon Manaloto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1640 E Verlea Dr, Tempe, AZ 85282 Phone: 602-300-8955 | |
Megan Flesner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1761 E Warner Rd Ste B1, Tempe, AZ 85284 Phone: 480-882-4934 |